Tizanidine

Historical note and nomenclature
Article section 1 of 12.  Next

By K K Jain MD

Tizanidine is a centrally acting alpha2-adrenergic agonist that was approved as an antispastic drug by the United States Food and Drug Administration in 1996.

In This Article

Historical note and nomenclature
Pharmacology
Clinical trials
Indications
Contraindications
Goals and duration of treatment
Dosing
Precautions and use in special groups
Interactions
Adverse effects
References cited
Contributors